The new coronavirus infectious disease (Corona 19) vaccine, which will be introduced to Korea for the first time at the beginning of next month, has been confirmed as a Pfizer vaccine supplied through’CoVax Facility’, a multinational vaccine supply alliance.
Sye-gyun Jeong “I got a call in early February?”
Come before the Astra vaccine
“Novabacks for 20 million people will be secured soon”
– An official from the quarantine authorities who requested anonymity said on the 20th that “out of the 10 million contracted with Kovacs facilities early next month, the 50,000 who will arrive first are Pfizer vaccines.” Earlier on this day, Prime Minister Jeong Sye-gyun appeared on MBC radio and said, “I answered that I would receive a call in early February (from Kobax) and I am preparing now.” Korea has secured 10 million people through COVAX, but the specific timing of introduction and type of vaccine have not been confirmed so far.
Pfizer vaccine must be distributed around -70 degrees Celsius. For this reason, there was a high possibility that the initial volume of Kovacs would be distributed to countries that secured the’cold chain’. In addition to Kovacs, the government signed a supply contract with AstraZeneca for 10 million, Janssen for 6 million, Pfizer for 10 million, and Modena for 20 million.
In addition, the government announced on the 20th that it will secure an additional 20 million copies of the US NovaVax’s Corona 19 vaccine (NVX-CoV2372).
President Moon Jae-in discussed the transfer of vaccine technology and the domestic supply method with Stanley Erkhnovavacs representative through a videoconference. The NovaVax vaccine is a product commissioned by SK Bioscience, and this is the first time that SK Bioscience has promoted a plan to supply the Corona 19 vaccine to Korea through technology transfer. As a result, the number of Corona 19 vaccines secured by the government will increase to 76 million people. It is 146.7% of the population (5182 million)
President Moon visited the SK Bio factory in Andong, Gyeongsangbuk-do this morning, toured the vaccine production site, and said, “It has a special meaning to receive not only production but also technology transfer,” he said. I said. The Blue House predicted that the contract will be made as early as this month, and explained that “the vaccine will be supplied as early as May.” NovaVax vaccine is a’synthetic antigen vaccine’ that is synthesized by genetic recombination technology by selecting only some proteins of viruses (antigens) that cause an immune response.
Representative Stanley said in a videoconference with President Moon, “We are conducting a phase 3 experiment in three countries, including South Africa, the United States, and the United Kingdom, and it will prove its effectiveness.” The final clinical results are expected to be reported in the first quarter of this year. NovaVax vaccine can be stored refrigerated (2-8 degrees of video), so it is more advantageous in distribution than Pfizer vaccine (minus 70 degrees) or Moder vaccine (minus 20 degrees).
Reporters Minwook Kim and Heechul Moon [email protected]
–
